UK Markets closed

Global Remote Patient Monitoring Systems Market to Reach $8.1 Billion by 2030

ReportLinker
·26-min read
ReportLinker
ReportLinker

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet.

New York, March 07, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Global Remote Patient Monitoring Systems Industry" - https://www.reportlinker.com/p05818127/?utm_source=GNW
Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Remote Patient Monitoring Systems Market to Reach $8.1 Billion by 2030

In the changed post COVID-19 business landscape, the global market for Remote Patient Monitoring Systems estimated at US$2.1 Billion in the year 2022, is projected to reach a revised size of US$8.1 Billion by 2030, growing at aCAGR of 18.4% over the period 2022-2030. Special Monitors, one of the segments analyzed in the report, is projected to record 17.5% CAGR and reach US$6.4 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Vital Sign Monitors segment is readjusted to a revised 22.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $614 Million, While China is Forecast to Grow at 17.4% CAGR

The Remote Patient Monitoring Systems market in the U.S. is estimated at US$614 Million in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 17.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 15.7% and 14.8% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.1% CAGR.

Select Competitors (Total 162 Featured)
- Biotronik SE & Co. KG
- F. Hoffmann-La Roche AG
- Intel Corporation
- Johnson & Johnson
- Koninklijke Philips NV
- Medtronic of Canada Ltd.
- Philips Healthcare
- Robert Bosch GmbH
- Welch Allyn, Inc.


Read the full report: https://www.reportlinker.com/p05818127/?utm_source=GNW

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Remote Patient Monitoring Systems - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific and Rest of World
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2022 through 2030 and % CAGR

Table 2: World Historic Review for Remote Patient Monitoring
Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 3: World 16-Year Perspective for Remote Patient
Monitoring Systems by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets for Years 2014, 2023 &
2030

Table 4: World Recent Past, Current & Future Analysis for Vital
Sign Monitors by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 5: World Historic Review for Vital Sign Monitors by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 6: World 16-Year Perspective for Vital Sign Monitors by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 7: World Recent Past, Current & Future Analysis for
Special Monitors by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 8: World Historic Review for Special Monitors by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 9: World 16-Year Perspective for Special Monitors by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 10: World Recent Past, Current & Future Analysis for
Cancer by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 11: World Historic Review for Cancer by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 12: World 16-Year Perspective for Cancer by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 13: World Recent Past, Current & Future Analysis for
Cardiovascular Diseases by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 14: World Historic Review for Cardiovascular Diseases by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 15: World 16-Year Perspective for Cardiovascular Diseases
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 16: World Recent Past, Current & Future Analysis for
Diabetes by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 17: World Historic Review for Diabetes by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 18: World 16-Year Perspective for Diabetes by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World for Years
2014, 2023 & 2030

Table 19: World Recent Past, Current & Future Analysis for
Sleep Disorder by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 20: World Historic Review for Sleep Disorder by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 21: World 16-Year Perspective for Sleep Disorder by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 22: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 23: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 24: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 25: World Recent Past, Current & Future Analysis for
Hospital based Patients by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 26: World Historic Review for Hospital based Patients by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 27: World 16-Year Perspective for Hospital based Patients
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 28: World Recent Past, Current & Future Analysis for
Ambulatory Patients by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific and Rest of World Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 29: World Historic Review for Ambulatory Patients by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 30: World 16-Year Perspective for Ambulatory Patients by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 31: World Recent Past, Current & Future Analysis for Home
Healthcare by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 32: World Historic Review for Home Healthcare by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific and Rest of World Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2014 through 2021 and
% CAGR

Table 33: World 16-Year Perspective for Home Healthcare by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 34: World Recent Past, Current & Future Analysis for
Hypertension by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific and Rest of World Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2022 through
2030 and % CAGR

Table 35: World Historic Review for Hypertension by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific and
Rest of World Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2014 through 2021 and % CAGR

Table 36: World 16-Year Perspective for Hypertension by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of
World for Years 2014, 2023 & 2030

Table 37: World Remote Patient Monitoring Systems Market
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2030

III. MARKET ANALYSIS

UNITED STATES
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2023 (E)
Table 38: USA Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by Product Type - Special Monitors
and Vital Sign Monitors - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 39: USA Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 40: USA 16-Year Perspective for Remote Patient Monitoring
Systems by Product Type - Percentage Breakdown of Value Sales
for Special Monitors and Vital Sign Monitors for the Years
2014, 2023 & 2030

Table 41: USA Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 42: USA Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 43: USA 16-Year Perspective for Remote Patient Monitoring
Systems by Application - Percentage Breakdown of Value Sales
for Diabetes, Hypertension, Cancer, Cardiovascular Diseases,
Sleep Disorder and Other Applications for the Years 2014, 2023 &
2030

Table 44: USA Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 45: USA Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 46: USA 16-Year Perspective for Remote Patient Monitoring
Systems by End-Use - Percentage Breakdown of Value Sales for
Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

CANADA
Table 47: Canada Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 48: Canada Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 49: Canada 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 50: Canada Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 51: Canada Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 52: Canada 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 53: Canada Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 54: Canada Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 55: Canada 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

JAPAN
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 56: Japan Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 57: Japan Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 58: Japan 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 59: Japan Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 60: Japan Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 61: Japan 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 62: Japan Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 63: Japan Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 64: Japan 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

CHINA
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 65: China Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 66: China Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 67: China 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 68: China Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 69: China Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 70: China 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 71: China Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 72: China Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 73: China 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

EUROPE
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 74: Europe Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Geographic Region -
France, Germany, Italy, UK and Rest of Europe Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2022 through 2030 and % CAGR

Table 75: Europe Historic Review for Remote Patient Monitoring
Systems by Geographic Region - France, Germany, Italy, UK and
Rest of Europe Markets - Independent Analysis of Annual Sales
in US$ Thousand for Years 2014 through 2021 and % CAGR

Table 76: Europe 16-Year Perspective for Remote Patient
Monitoring Systems by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK and Rest of
Europe Markets for Years 2014, 2023 & 2030

Table 77: Europe Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 78: Europe Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 79: Europe 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 80: Europe Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 81: Europe Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 82: Europe 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 83: Europe Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 84: Europe Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 85: Europe 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

FRANCE
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 86: France Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 87: France Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 88: France 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 89: France Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 90: France Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 91: France 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 92: France Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 93: France Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 94: France 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

GERMANY
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 95: Germany Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 96: Germany Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 97: Germany 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 98: Germany Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 99: Germany Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 100: Germany 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 101: Germany Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 102: Germany Historic Review for Remote Patient
Monitoring Systems by End-Use - Hospital based Patients,
Ambulatory Patients and Home Healthcare Markets - Independent
Analysis of Annual Sales in US$ Thousand for Years 2014 through
2021 and % CAGR

Table 103: Germany 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

ITALY
Table 104: Italy Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Product Type - Special
Monitors and Vital Sign Monitors - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2022 through 2030
and % CAGR

Table 105: Italy Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 106: Italy 16-Year Perspective for Remote Patient
Monitoring Systems by Product Type - Percentage Breakdown of
Value Sales for Special Monitors and Vital Sign Monitors for
the Years 2014, 2023 & 2030

Table 107: Italy Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 108: Italy Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 109: Italy 16-Year Perspective for Remote Patient
Monitoring Systems by Application - Percentage Breakdown of
Value Sales for Diabetes, Hypertension, Cancer, Cardiovascular
Diseases, Sleep Disorder and Other Applications for the Years
2014, 2023 & 2030

Table 110: Italy Recent Past, Current & Future Analysis for
Remote Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 111: Italy Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 112: Italy 16-Year Perspective for Remote Patient
Monitoring Systems by End-Use - Percentage Breakdown of Value
Sales for Hospital based Patients, Ambulatory Patients and Home
Healthcare for the Years 2014, 2023 & 2030

UNITED KINGDOM
Remote Patient Monitoring Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2023 (E)
Table 113: UK Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by Product Type - Special Monitors
and Vital Sign Monitors - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 114: UK Historic Review for Remote Patient Monitoring
Systems by Product Type - Special Monitors and Vital Sign
Monitors Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2014 through 2021 and % CAGR

Table 115: UK 16-Year Perspective for Remote Patient Monitoring
Systems by Product Type - Percentage Breakdown of Value Sales
for Special Monitors and Vital Sign Monitors for the Years
2014, 2023 & 2030

Table 116: UK Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by Application - Diabetes,
Hypertension, Cancer, Cardiovascular Diseases, Sleep Disorder
and Other Applications - Independent Analysis of Annual Sales
in US$ Thousand for the Years 2022 through 2030 and % CAGR

Table 117: UK Historic Review for Remote Patient Monitoring
Systems by Application - Diabetes, Hypertension, Cancer,
Cardiovascular Diseases, Sleep Disorder and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2014 through 2021 and % CAGR

Table 118: UK 16-Year Perspective for Remote Patient Monitoring
Systems by Application - Percentage Breakdown of Value Sales
for Diabetes, Hypertension, Cancer, Cardiovascular Diseases,
Sleep Disorder and Other Applications for the Years 2014, 2023 &
2030

Table 119: UK Recent Past, Current & Future Analysis for Remote
Patient Monitoring Systems by End-Use - Hospital based
Patients, Ambulatory Patients and Home Healthcare - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2022
through 2030 and % CAGR

Table 120: UK Historic Review for Remote Patient Monitoring
Systems by End-Use - Hospital based Patients, Ambulatory
Patients and Home Healthcare Markets - Independent Analysis of
Annual Sales in US$ Thousand for Years 2014 through 2021 and %
CAGR

Table 121: UK 16-Year Perspective for Remote Patient Monitoring
Systems by End-Use - Percentage Breakdown of Value Sales for
Hospital based Patients, Ambulatory Patients and Home

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05818127/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001


Latest stories

  • Ovo launches first energy deal below Government price cap as gas tumbles

    One of Britain’s biggest energy providers has offered its first deal cheaper than the Government’s bill guarantee, as falling gas prices finally bring savings for customers.

  • One meter for your home, another for your EV: How the EU's new energy system could save you money

    An electricity market redesign is under way, aimed at shielding consumers from price spikes and boosting the rollout of renewables.

  • India Set to Surpass China in Need for Oil as Growth Paths Diverge

    (Bloomberg) -- A change is on the horizon for oil demand, with India set to eclipse China as the most important driver of global growth — and potentially the last, as the world shifts to a greener future.Most Read from BloombergDeutsche Bank Slumps in Resurgence of European Bank WorriesJack Dorsey’s Wealth Tumbles $526 Million After Hindenburg ShortUBS Sends Khan to Stem Credit Suisse’s Private Banker ExitsJack Dorsey’s Block Vows to Fight Back After Hindenburg Says It’s Short the StockA swellin

  • How Texas plans to be the bitcoin mining capital

    STORY: Bitcoin mining is booming in Texas with 25 facilities already operating across rural areas.Crypto mining consumes huge amounts of electricitybut the state is well placed to provide this power cheaply even while the industry faces a proposed 30% tax on electricity usage.Joshua Rhodes is a research scientist at the University of Texas.“The price out in West Texas can be very low, sometimes negative. And because, you know, 80 to 90% of the input into a crypto mining operation is electricity, you know, the cheaper that electricity is, the more attractive it can be.”Texas’s renewable energy sources like wind power is also inviting for miners. New York has already banned crypto mining that runs on fossil fuel power. Alongside the obvious climate concerns, for Liz Moran from environmental nonprofit Earthjustice, the crypto industry also fails to deliver on employment. "What's happening in a number of communities where these mining operations are coming in is they're promising a lot of jobs, but they're not delivering on a lot of jobs. So we absolutely need to be helping communities that have been economically struggling and getting more jobs. And we think the green energy sector is the way to go for that."Other states are expected to follow New York's lead - and that's narrowing the field for industry leaders like Matt Prusak, CCO of US Bitcoin Corp.“Environmentalists have many concerns around the environmental and the energy impact of Bitcoin mining. That's one of the reasons why US Bitcoin Corp, we've really tried our best to co-locate at or near wind, solar and other renewable energy sources.”Power usage by bitcoin miners rose 75% last year, according to Lee Bratcher from the Texas Blockchain Council"There is about 2,100 megawatts worth of Bitcoin mining in Texas, and that's up from around 1,200 last year and less than 600 the year before. So it's, it's growing considerably and that's at around 25 facilities across the state, mostly in rural areas, creating jobs and tax revenue for rural counties throughout the state of Texas."However, the prospect of higher crypto demand on Texas’s grid has raised concerns.In the state, around 250 people died in a winter storm blackout exposing the fragility of its power system.The state is taking steps to maintain a reliable grid.Lee Bratcher again:“If power is in high demand, prices are high, power is in low demand, prices are low. And Bitcoin miners need those price signals. And we as citizens, who want a reliable grid, we want those price signals because we want people to consume electricity when there's too much of it. And we want people to curtail their energy use when there's not enough.”

  • Oil Prices Crash 4% As European Banking Stocks Slump

    Oil prices plunged on Friday morning as banking stocks in Europe crashed while the U.S. dollar rallied.

  • German power grid firms list costs to meet zero-carbon targets

    Boosting German power transmission lines to accommodate a shift to zero-carbon generation industry will require 14,197 km (8821.61 miles) of new networks costing billions of euros, the country's high voltage grid firms (TSOs) said on Friday. The operators' costs are mainly shouldered by consumers via grid usage fees, which account for about a quarter of electricity bills.

  • China's CATL to start mass output of M3P batteries this year

    SHANGHAI (Reuters) -Chinese battery giant CATL plans to start this year the mass production and delivery of batteries based on a new materials technology, M3P, which will perform better and cost less than nickel and cobalt-based ones, its chairman said. M3P batteries will have greater energy density and perform better than lithium-ion phosphate batteries, a market CATL dominates. CATL disclosed in August last year that it was working on M3P technology, which can enable an electric vehicle to run 700 km (430 miles) per charge when combined with CATL's next generation of battery-pack technology.

  • Copper prices could soar 33% in the next year as global inventories hit lowest since 2008, top metals trader says

    China's reopening and renewable-energy industries are accelerating demand, and prices may rise to $12,000 per metric ton, according to Trafigura.

  • Oil Prices Set For Weekly Gain Despite Demand Fears

    Oil prices are on course for a weekly gain after the recent crash, driven higher by hopes that the Fed may halt its interest rate hikes and Chinese demand will return.

  • Apple CEO praises China's innovation, long history of cooperation on Beijing visit

    Apple CEO Tim Cook on Saturday used his first public remarks on his visit to China to praise the country for its rapid innovation and its long ties with the U.S. iPhone maker, according to local media reports. Apple CEO Tim Cook on Saturday used his first public remarks in China in recent years to praise the country for its rapid innovation and its long ties with the U.S. iPhone maker, according to local media reports.

  • 'Dressing digitally' pins hope on blockchain to clean up fashion's carbon footprint

    The fashion industry is responsible for almost 8% of global CO2 emissions. Can 'digital dressing' make a difference?

  • Hindenburg Research’s claims against Block ‘wishy-washy,’ analyst says

    Mizuho Senior Financial Technology Analyst Dan Dolev joins Yahoo Finance Live to discuss Hindenburg Research’s claims against Block, the decline in stock for the mobile payment company, payment app competition, and the outlook for Block.

  • Ford CEO: Tesla is going to see 'more price competition' in the EV market

    Ford CEO Jim Farley is all in on taking the fight to Tesla.

  • Financial turbulence widens door to private equity in fast-growing aerospace sector

    Financial sector headwinds are creating fresh openings for private equity investments in aerospace, as suppliers' need for capital to meet soaring demand for planes and parts risks further turbulence, executives said. Demand from aircraft manufacturing giants has soared on the back of surging global air travel following a pandemic-induced slump. "While the overall economy may see slower growth or enter into a recession, aerospace suppliers need capital now to support the significant increased demand," said Charlie Compton, partner at Boca Raton, Florida-based AE Industrial Partners, a private equity firm specializing in investments in aerospace and other sectors.

  • Chinese smartphone maker Xiaomi's revenue and profit slides

    SHANGHAI (Reuters) -Chinese smartphone maker Xiaomi Corp on Friday reported a record drop in fourth-quarter revenue as the company weathered a slowdown in consumption and disruptions due to China's COVID-19 curbs. Early signs suggest China's economy will only rebound slowly, as consumers remain cautious about spending money despite an easing of restrictions on domestic and international travel. Xiaomi group president Lu Weibing, speaking on a company earnings call, said China's consumer electronics was seeing early signs of a recovery at present but "it will take time."

  • Banking regulators increase scrutiny of 'shadow' bank exposures

    Global banking regulators will step up scrutiny of how risks from systemically important shadow banks could destabilise lenders, a top banking regulator said on Friday as central bankers home in on the huge funds industry. Non-bank financial intermediaries (NBFI) - known as shadow banks - also include insurers and now make up nearly half the world's financial assets, raising concerns among central banks about threats to overall financial stability.

  • Norway, Sweden, Finland, and Denmark struck a deal to run their 200+ advanced fighter jets as a single fleet, creating a new headache for Russia

    Norway, Denmark, and Finland operate the top-tier F-35 fighter jets, while Sweden has its own Gripen E planes.

  • Singer Explains Why She “Butchered” UK National Anthem In Front Of Thousands Of Football Fans

    A singer has apologised for “butchering” the British national anthem at an England football match on Thursday evening. Italian-American singer Ellynora had been asked to perform God Save the King before the kick-off of the European Championship qualifier match in Napoli. However, she appeared to have trouble with the song, singing off-key, repeating the first […]

  • Woman who claims to be Maddie McCann sends message to Kate McCann: 'I feel like I know your voice'

    Julia Wendell, who claims to be Kate and Gerry McCann’s missing daughter, Madeleine McCann, has now shared a message to the couple, saying that she truly believes she could be their daughter - and if not then she believes that she was abused by the same perpetrator who kidnapped the then-three-year-old back in 2007. Speaking in an exclusive interview with Radar Online, she explained: "I really believe that I can be Madeleine, your daughter, but if I’m not then I’m over 100 per cent sure that the

  • Dozens of people view down street to view two-bedroom house in East London

    52 people reportedly queued up to visit a two-bedroom house in East Londonhasnainadeel